Stock Screener App

Frei -

Installieren

10.88

3.40% 0.4346

Immix Biopharma Inc (IMMX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten

Price to book forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView

Immix Biopharma, Inc. Financial Disclosures & SEC Filings - TradingView

Wall Street analysts think Immix Biopharma (IMMX) could surge 113.58%: Read this before placing a bet - MSN

IMMX News | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill

Wall Street analysts see a 120.59% upside in Immix Biopharma (IMMX): Can the stock really move this high? - MSN

Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Index - marketscreener.com

Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2500 Growth Benchmark - marketscreener.com

Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Growth Benchmark - marketscreener.com

Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000E Growth Benchmark - marketscreener.com

Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000 Growth Benchmark - marketscreener.com

Immix Biopharma, Inc. Actuals & Estimates (NASDAQ:IMMX) - TradingView

IMMX Forecast — Price Target — Prediction for 2027 - TradingView

Immix Biopharma Inc (IMMX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Immix Biopharma analyst bullish but flags safety, adoption questions - MSN

All you need to know about Immix Biopharma (IMMX) rating upgrade to buy - MSN

All You Need to Know About Immix Biopharma (IMMX) Rating Upgrade to Buy - Yahoo Finance

Immix Biopharma, Inc.(NasdaqCM: IMMX) added to S&P Biotechnology Select Industry Index - marketscreener.com

Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions - Benzinga

BofA initiates Immix Biopharma stock with buy rating on AL amyloidosis drug - Investing.com UK

Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet - Yahoo Finance

Immix Biopharma, Inc. Stock 12‑Month Price Target Raised to $19.79, Implies 117% Upside - TradingView

IMMX Initiates Coverage by B of A Securities -- Rating Set to Bu - GuruFocus

This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

BofA Securities Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $27 - Moomoo

Immix Biopharma Inc (IMMX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Immix Biopharma Inc (IMMX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Immix Biopharma Inc (IMMX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

IMMX Initiates Coverage On LifeSci Capital -- Rating at Outperfo - GuruFocus

Immix Biopharma Inc (IMMX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Immix Biopharma Inc (IMMX) Institutional Confidence - TradingKey

Immix Biopharma Inc (IMMX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Immix Biopharma Inc (IMMX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Immix Biopharma Inc (IMMX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Immix Biopharma Initiated at Outperform by LifeSci Capital - Moomoo

IMMX Q1 2026 Earnings: EPS Beat Reflects Cost Discipline Amid Pre-Revenue Biotech Pipeline ProgressProfit Guidance Range - newsline.com

IMMX Q1 2026 Earnings: Biotech Reports Narrower-than-Expected Loss, Shares GainEPS Estimate Trend - newsline.com

Immix Biopharma Surges 5.3% as Biotech Sentiment Lifts IMMXProfit Surge Picks - newsline.com

Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st

What's going on with Immix Biopharma stock Thursday? - MSN

Janus Henderson files 13G/A: 9.09M shares of Immix Biopharma (IMMX) - Stock Titan

These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations - Seeking Alpha

IMMX Technical Analysis | Trend, Signals & Chart Patterns | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill

Immix Biopharma, Inc. Files Form 8-K Announcing Election of Directors and Corporate Details (May 2026) - Minichart

Immix Biopharma Shareholders Back Board and Auditor at AGM - TipRanks

Immix Biopharma (NASDAQ: IMMX) posts 2026 annual shareholder voting outcomes - Stock Titan

Immix Biopharma (IMMX) awards RSUs and stock options to director Helen Adams - Stock Titan

Immix Biopharma (IMMX) director Carey Ng awarded RSUs, 12,500-share option - Stock Titan

Immix Biopharma (NASDAQ: IMMX) grants RSUs and stock options to director - Stock Titan

Immix Biopharma (IMMX) CFO, President awarded 500,000 stock options at $8.78 - Stock Titan

Immix Biopharma (IMMX) director receives 6,250 RSUs and 12,500 options - Stock Titan

Immix Biopharma (IMMX) awards CEO 500,000 stock options at $8.78 strike - Stock Titan

Immix Biopharma (IMMX) director awarded RSUs and stock options in new grants - Stock Titan

Immix Biopharma (IMMX) board member receives new RSU and stock option awards - Stock Titan

Immix Biopharma (IMMX) director Jane Buchan awarded RSUs and 12,500 stock options - Stock Titan

Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Ng Carey - Moomoo

Immix Biopharma Q1 2026 Earnings: Narrower-than-Expected Loss Drives Modest Stock UptickQuarterly Profit Report - newsline.com

INSM

$113.49

1.16%

ROIV

$35.27

0.23%

RPRX

$57.95

1.95%

ONC

$308.33

0.48%

MRNA

$82.23

0.32%

RVMD

$190.47

0.31%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters